Volume 29, Number 4—April 2023
CME ACTIVITY - Synopsis
Pediatric Invasive Meningococcal Disease, Auckland, New Zealand (Aotearoa), 2004–2020
Table 3
Variable |
No. cases (%) |
OR (95% CI) |
p value |
Ethnicity, compared with non-Māori, non-Pacific population | |||
Pacific | 38/118 (32.2) | 2.91 (1.31–7.18) | 0.0128 |
Māori |
28/96 (29.2) |
2.52 (1.10–6.35) |
0.0366 |
Reduced penicillin susceptibility |
12/64 (18.8) |
0.548 (0.25–1.14) |
0.117 |
NZDep quintile† |
271 |
1.21 (0.95–1.58) |
0.142 |
Age, mo† |
271 |
0.996 (0.99–1.00) |
0.157 |
Serogroup, compared with MenB | |||
MenC | 7/18 (38.9) | 1.80 (0.64–4.82) | 0.247 |
MenW | 6/25 (24.0) | 0.89 (0.31–2.24) | 0.822 |
MenY |
3/8 (37.5) |
1.70 (0.34–7.16) |
0.478 |
Male sex, compared with female |
50/168 (29.8) |
1.39 (0.80–2.48) |
0.248 |
Season, compared with autumn | |||
Spring | 23/76 (30.3) | 1.47 (0.64–3.60) | 0.374 |
Summer | 11/35 (31.4) | 1.56 (0.57–4.31) | 0.386 |
Winter |
30/116 (25.9) |
1.19 (0.54–2.79) |
0.683 |
MeNZB vaccination, compared with fully vaccinated | |||
Unvaccinated | 43/166 (25.9) | 0.76 (0.39–1.51) | 0.425 |
Partially vaccinated |
12/41 (29.3) |
0.90 (0.37–2.17) |
0.817 |
Prehospital parenteral antibiotic treatment |
10/44 (22.7) |
0.79 (0.35–1.64) |
0.537 |
Sepsis criteria | 39/145 (26.9) | 1.14 (0.51–2.77) | 0.751 |
*Men, Neisseria meningitidis serogroup; OR, odds ratio; NZDep, New Zealand Index of Deprivation †Continuous variable; OR represents increase in odds for each unit increase in variable.
Page created: February 01, 2023
Page updated: March 16, 2023
Page reviewed: March 16, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.